MARKET

SLNO

SLNO

SOLENO THERAPEUT
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.830
+0.030
+1.67%
Opening 13:03 08/13 EDT
OPEN
1.790
PREV CLOSE
1.800
HIGH
1.900
LOW
1.790
VOLUME
212.90K
TURNOVER
--
52 WEEK HIGH
4.390
52 WEEK LOW
1.180
MARKET CAP
145.66M
P/E (TTM)
-2.3683
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SLNO stock price target is 8.50 with a high estimate of 9.00 and a low estimate of 8.00.

EPS

SLNO News

More
Soleno Therapeutics EPS beats by $0.04
Soleno Therapeutics (NASDAQ:SLNO): Q2 GAAP EPS of -$0.16 beats by $0.04. Cash and cash equivalents of ~$62.5M. Press Release
seekingalpha · 2d ago
Soleno Therapeutics Q2 EPS $(0.16) Up From $(0.31) YoY
Soleno Therapeutics (NASDAQ:SLNO) reported quarterly losses of $(0.16) per share. This is a 48.39 percent increase over losses of $(0.31) per share from the same period last year.
Benzinga · 2d ago
Soleno (SLNO) to report Q2 Earnings: What's in the Cards?
We expect Soleno (SLNO) to provide its clinical program updates when its releases second-quarter 2020 results.
Zacks · 07/27 14:09
MU, SPG among premarket gainers
Seeking Alpha - Article · 06/30 12:21
Have Insiders Been Buying Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares?
Simply Wall St. · 06/29 14:07
Trade Alert: Jack Schuler At Soleno Therapeutics, Inc. (NASDAQ:SLNO), Has Just Spent US$8.5m Buying 83% More Shares
Simply Wall St. · 06/29 14:02
Russell adds lineup of healthcare firms to key indexes
Seeking Alpha - Article · 06/29 12:25
Soleno Therapeutics Added To Russell 3000 Index
Benzinga · 06/29 12:21

Industry

Biotechnology & Medical Research
+0.93%
Pharmaceuticals & Medical Research
-1.19%

Hot Stocks

Symbol
Price
%Change

About SLNO

Soleno Therapeutics, Inc., formerly Capnia, Inc., is a healthcare company that develops and commercializes neonatology devices and diagnostics. The Company also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. The Company offers products, such as CoSense end-tidal carbon monoxide (ETCO) Monitor, NeoPIP Infant Resuscitator and Accessories, and Serenz Nasal Relief. The Company has developed the CoSense End-Tidal Carbon Monoxide Monitor that measures ETCO for the detection of dangerous hemolysis rates. The Infant Solutions product line, including the NeoPIP Infant Resuscitator Unit and accessories, is designed for controlled and accurate resuscitation of neonates and infants in the clinical environment. Serenz Nasal Relief is a hand-held nasal irrigator that uses carbon dioxide (CO2) gas to wash the nasal passages.
More

Webull offers kinds of Soleno Therapeutics Inc stock information, including NASDAQ:SLNO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLNO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SLNO stock methods without spending real money on the virtual paper trading platform.